MedTrace Logo

Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma

NCT01326390 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2016-07-01

No results posted yet for this study

Summary

Impact on contrast dose or total volume of contrast required to effectively treat the targeted tumor.

Conditions

  • Kidney (Renal Cell) Cancer

Interventions

DEVICE

dTA/dBA C-arm fluoroscopy system with Dyna CT

C-arm CT of the liver; state-of-the-art flat panel detector on a ceiling or floor mounted C-arm gantry

PROCEDURE

DSA arteriogram- hepatic arteries

Standard of care

PROCEDURE

CO2 aortogram

Standard of care

Sponsors & Collaborators

Principal Investigators

  • Nishita N. Kothary · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01326390 on ClinicalTrials.gov